Key Documents

View All Documentation

A79000

4-Aminoquinaldine

Name: 4-Aminoquinaldine
Brand: ALDRICH

98%

Synonym(s):

2-Methyl-4-quinolinamine, 4-Amino-2-methylquinoline, 4-Quinaldinamine, NSC 60281

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₀H₁₀N₂

CAS Number:

6628-04-2

Molecular Weight:

158.20

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24891290

EC Number:

229-604-4

Beilstein/REAXYS Number:

118323

MDL number:

MFCD00006759

Assay:

98%

Form:

powder

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

98%

form

powder

bp

333 °C (lit.)

mp

162-166 °C (lit.)

SMILES string

Cc1cc(N)c2ccccc2n1

InChI

1S/C10H10N2/c1-7-6-9(11)8-4-2-3-5-10(8)12-7/h2-6H,1H3,(H2,11,12)

InChI key

COCFIBRMFPWUDW-UHFFFAOYSA-N

Description

Still not finding the right product?

Explore all of our products under 4-Aminoquinaldine

pictograms

GHS07

signalword

Warning

hcodes

H315,H319,H335

pcodes

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic efficacy against morphine dependence.

Ishani Deb et al.

Bioorganic & medicinal chemistry, 17(16), 5782-5790 (2009-07-31)

Based on an established 3D pharmacophore, a series of quinoline derivatives were synthesized. The opioidergic properties of these compounds were determined by a competitive binding assay using (125)I-Dynorphine, (3)H-DAMGO and (125)I-DADLE for kappa, mu, and delta receptors, respectively. Results showed

Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.

Stefania Ferrari et al.

Journal of medicinal chemistry, 54(1), 211-221 (2010-12-04)

Folate analogue inhibitors of Leishmania major pteridine reductase (PTR1) are potential antiparasitic drug candidates for combined therapy with dihydrofolate reductase (DHFR) inhibitors. To identify new molecules with specificity for PTR1, we carried out a virtual screening of the Available Chemicals

Global Trade Item Number

SKU	GTIN
A79000-25G	04061833324448
A79000-5G	04061833386590